GW Pharmaceuticals Exposes Risks of Investing in Medical Marijuana
The phase 3 failure of Sativex for cancer pain reminds investors of the risks of investing in marijuana stocks.
7 States That Would Benefit Most From Legal Marijuana
Do you live in one of the seven states that would benefit most from a sweeping legalization of marijuana?
Will Marijuana Stocks Soar in 2015?
Here are the catalysts that could make GW Pharmaceuticals and Insys trade higher or lower next year.
This Is Potentially Bad News for the Legal Marijuana Movement
Marijuana's market potential is enormous, but studies like this one could set marijuana's recent progress back a notch or two.